Literature DB >> 12844362

Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice.

Chad Creighton1, Rork Kuick, David E Misek, David S Rickman, Franck M Brichory, Jean-Marie Rouillard, Gilbert S Omenn, Samir Hanash.   

Abstract

BACKGROUND: Tumor cells cultured in vitro are widely used to investigate the molecular biology of cancers and to evaluate responses to drugs and other agents. The full extent to which gene expression in cancer cells is modulated by extrinsic factors and by the microenvironment in which the cancer cells reside remains to be determined. Two cancer cell lines (A549 lung adenocarcinoma and U118 glioblastoma) were transplanted subcutaneously into immunodeficient mice to form tumors. Global gene-expression profiles of the tumors were determined, based on analysis of expression of human genes, and compared with expression profiles of the cell lines grown in culture.
RESULTS: A bioinformatics approach associated genes that showed changes in their expression levels with functional classes as defined by either the GO gene annotations or MeSH terms in the literature. The classes of genes expressed at higher levels in cells grown in vitro indicated increased cell division and metabolism, reflecting the more favorable environment for cell proliferation. In contrast, in vivo tumor growth resulted in upregulation of a significant number of genes involved in the extracellular matrix (ECM), cell adhesion, cytokine and metalloendopeptidase activity, and neovascularization. When placed in comparable tissue environments, the U118 cells and the A549 cells expressed different sets of ECM and cell adhesion-related genes, suggesting different mechanisms of extracellular interaction at work in the different cancers.
CONCLUSIONS: Studies of this type allow us to examine the specific contribution of cancer cells to gene expression patterns within an in vivo tumor mixed with non-cancerous tissue.

Entities:  

Mesh:

Year:  2003        PMID: 12844362      PMCID: PMC193633          DOI: 10.1186/gb-2003-4-7-r46

Source DB:  PubMed          Journal:  Genome Biol        ISSN: 1474-7596            Impact factor:   13.583


  22 in total

1.  RefSeq and LocusLink: NCBI gene-centered resources.

Authors:  K D Pruitt; D R Maglott
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

2.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  Gene expression patterns define pathways correlated with loss of differentiation in lung adenocarcinomas.

Authors:  Chad Creighton; Samir Hanash; David Beer
Journal:  FEBS Lett       Date:  2003-04-10       Impact factor: 4.124

4.  The distribution of secondary growths in cancer of the breast. 1889.

Authors:  S Paget
Journal:  Cancer Metastasis Rev       Date:  1989-08       Impact factor: 9.264

Review 5.  Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer.

Authors:  M A Rubin
Journal:  J Pathol       Date:  2001-09       Impact factor: 7.996

6.  Blocking sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis.

Authors:  F Verrecchia; J Rossert; A Mauviel
Journal:  J Invest Dermatol       Date:  2001-05       Impact factor: 8.551

7.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.

Authors:  A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

8.  Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice.

Authors:  Chad Creighton; Rork Kuick; David E Misek; David S Rickman; Franck M Brichory; Jean-Marie Rouillard; Gilbert S Omenn; Samir Hanash
Journal:  Genome Biol       Date:  2003-06-23       Impact factor: 13.583

9.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Authors:  Donald R Schwartz; Sharon L R Kardia; Kerby A Shedden; Rork Kuick; George Michailidis; Jeremy M G Taylor; David E Misek; Rong Wu; Yali Zhai; Danielle M Darrah; Heather Reed; Lora H Ellenson; Thomas J Giordano; Eric R Fearon; Samir M Hanash; Kathleen R Cho
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

View more
  19 in total

Review 1.  An integrated strategy for the optimization of microarray data interpretation.

Authors:  Xinmin Li; Richard J Quigg
Journal:  Gene Expr       Date:  2005

2.  Transcriptional response of the murine mammary gland to acute progesterone exposure.

Authors:  Rodrigo Fernandez-Valdivia; Atish Mukherjee; Chad J Creighton; Adam C Buser; Francesco J DeMayo; Dean P Edwards; John P Lydon
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

3.  A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions.

Authors:  Chad J Creighton; Ankur K Nagaraja; Samir M Hanash; Martin M Matzuk; Preethi H Gunaratne
Journal:  RNA       Date:  2008-09-23       Impact factor: 4.942

4.  Robust global microRNA expression profiling using next-generation sequencing technologies.

Authors:  Shirley Tam; Richard de Borja; Ming-Sound Tsao; John D McPherson
Journal:  Lab Invest       Date:  2014-01-20       Impact factor: 5.662

5.  Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice.

Authors:  Chad Creighton; Rork Kuick; David E Misek; David S Rickman; Franck M Brichory; Jean-Marie Rouillard; Gilbert S Omenn; Samir Hanash
Journal:  Genome Biol       Date:  2003-06-23       Impact factor: 13.583

6.  Validation of a mouse xenograft model system for gene expression analysis of human acute lymphoblastic leukaemia.

Authors:  Amy L Samuels; Violet K Peeva; Rachael A Papa; Marin J Firth; Richard W Francis; Alex H Beesley; Richard B Lock; Ursula R Kees
Journal:  BMC Genomics       Date:  2010-04-21       Impact factor: 3.969

7.  Biochemical constitution of extracellular medium is critical for control of human breast cancer MDA-MB-231 cell motility.

Authors:  Huiyan Pan; Mustafa B A Djamgoz
Journal:  J Membr Biol       Date:  2008-06-25       Impact factor: 1.843

8.  Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells.

Authors:  Allan R Albig; Darryl J Becenti; Thessa G Roy; William P Schiemann
Journal:  Microvasc Res       Date:  2008-03-12       Impact factor: 3.514

9.  Global gene expression analysis of reactive stroma in prostate cancer.

Authors:  Olga Dakhova; Mustafa Ozen; Chad J Creighton; Rile Li; Gustavo Ayala; David Rowley; Michael Ittmann
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

10.  RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib.

Authors:  James R Bradford; Matthew Farren; Steve J Powell; Sarah Runswick; Susie L Weston; Helen Brown; Oona Delpuech; Mark Wappett; Neil R Smith; T Hedley Carr; Jonathan R Dry; Neil J Gibson; Simon T Barry
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.